The Newsroom

Robbins Arroyo LLP News  /  06.28.2018

Iovance Biotherapeutics, Inc. ( IOVA ) Shareholders

Iovance Biotherapeutics, Inc. ( IOVA ) Engaged in Illegal Stock Promotion Scheme According to SEC

Iovance Biotherapeutics, Inc. ( IOVA ) (formerly known as Lion Biotechnologies, Inc.)  violated federal securities laws by failing to disclose that the articles and e-mails they disseminated touting the company and promising future prospects to the investing public were actually paid promotions.  This scheme artificially inflated the value of the company’s stock and enriched the company’s CEO, whose compensation was linked to milestones dependent upon Iovance’s stock price increasing.  As a result, the Securities and Exchange commission imposed a $100,000 fine and Iovance is the subject of a securities class action lawsuit.

Do you own shares of Iovance Biotherapeutics, Inc. ( IOVA )?

For more information about your rights and potential remedies, please contact us via the contact form or email Leo Kandinov at LKandinov@robbinsarroyo.com

  • Please Note: Neither the submission to nor the receipt of information by Robbins Arroyo LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

How can we help you?

CONTACT US TODAY | 1-800-350-6003 or info@robbinsarroyo.com

Tell us your concerns